Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...

Everyone has a favourite video game tutorial. Maybe it's the first hour of Fallout 3, which quite literally treats you as a baby, teaching you new mechanics at different stages of growth? Perhaps it's ...

Cassie is a former deputy editor who collaborated with teams around the world while living in the beautiful hills of Kentucky. Focusing on bringing growth to small businesses, she is passionate about ...

Java developers absolutely must learn Maven. Maven is the most popular and pervasive build tool in the Java world. Even if you don't use Maven directly, alternatives such as Gradle, Jenkins or Ivy ...

Sam has loved video games and writing for as long as they can remember. When they aren't gaming or writing, they can be found watching motorsports and ice hockey. Tutorials are often the least ...

20-year-old Katie loves tutorial porn. The university student, who is using her first name only for privacy reasons, tells Mashable that it helped her to understand sex during a time where it ...

QuantHealth, an Israeli AI-enabled clinical trial-design startup, announced that David Dornstreich is joining the company as its general manager and chief commercial officer of U.S. operations, which ...

Allscripts Healthcare Solutions announced on Tuesday that the company will now be called Veradigm. In March 2022 the electronic health record vendor – which was founded in 1986 and grew through many ...

Allscripts is changing its corporate name to Veradigm, to reflect the health IT company’s focus on growth across each of its market segments, including payers, life sciences and providers, according ...

After shedding its hospital business segment earlier this year, health IT company Allscripts is doubling down on its strategy to grow its payers and life sciences businesses. Allscripts sold its ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.